LY3314814

LY3314814 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY3314814, covering 2018-06-28 to 2019-03-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3314814 in Healthy Participants [Phase 1]